Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency.

Tonelli M, Moyé L, Sacks FM, Kiberd B, Curhan G; Cholesterol and Recurrent Events (CARE) Trial Investigators.

Ann Intern Med. 2003 Jan 21;138(2):98-104.

PMID:
12529091
2.

Effect of pravastatin on cardiovascular events in people with chronic kidney disease.

Tonelli M, Isles C, Curhan GC, Tonkin A, Pfeffer MA, Shepherd J, Sacks FM, Furberg C, Cobbe SM, Simes J, Craven T, West M.

Circulation. 2004 Sep 21;110(12):1557-63. Epub 2004 Sep 13. Review.

4.

Atorvastatin: its clinical role in cerebrovascular prevention.

Gaspardone A, Arca M.

Drugs. 2007;67 Suppl 1:55-62. Review.

PMID:
17910521
5.

A prospective study of pravastatin in the elderly at risk: new hope for older persons.

Shepherd J.

Am J Geriatr Cardiol. 2004 May-Jun;13(3 Suppl 1):17-24. Review.

PMID:
15133425
6.
7.

Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events.

Arca M, Gaspardone A.

Drugs. 2007;67 Suppl 1:29-42. Review.

PMID:
17910519
8.

The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials.

Holdaas H, Wanner C, Abletshauser C, Gimpelewicz C, Isaacsohn J.

Int J Cardiol. 2007 Apr 12;117(1):64-74. Epub 2006 Aug 4. Review.

PMID:
16889855
9.

Lessons learned from the prospective pravastatin pooling project.

Byington RP, Sacks FM.

Curr Atheroscler Rep. 2004 Sep;6(5):366-74. Review.

PMID:
15296703
10.

Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis.

Gutierrez J, Ramirez G, Rundek T, Sacco RL.

Arch Intern Med. 2012 Jun 25;172(12):909-19. doi: 10.1001/archinternmed.2012.2145. Review.

PMID:
22732744
11.

Statins in the prevention of cardiovascular events in patients with renal failure.

Buemi M, Floccari F, Nostro L, Campo S, Caccamo C, Sturiale A, Aloisi C, Giacobbe MS, Frisina N.

Cardiovasc Hematol Disord Drug Targets. 2007 Mar;7(1):7-13. Review.

PMID:
17346123
12.

Impact of statins on cardiovascular outcomes in renal transplant recipients: a systematic review.

Maharjan N, Bedi U, Arora R, Bhandari S, Dahal P, Khosla S.

Am J Ther. 2011 May;18(3):e48-54. doi: 10.1097/MJT.0b013e3181cec203. Review.

PMID:
21048435
13.

Effect of statins on cardiovascular events in patients with mild to moderate chronic kidney disease: a systematic review and meta-analysis of randomized clinical trials.

Zhang X, Xiang C, Zhou YH, Jiang A, Qin YY, He J.

BMC Cardiovasc Disord. 2014 Feb 17;14:19. doi: 10.1186/1471-2261-14-19. Review.

14.

Evidence-based statin prescription for cardiovascular protection in renal impairment.

Fabbian F, De Giorgi A, Pala M, Tiseo R, Manfredini R, Portaluppi F.

Clin Exp Nephrol. 2011 Aug;15(4):456-63. doi: 10.1007/s10157-011-0454-9. Epub 2011 May 10. Review.

PMID:
21556807
15.

Pravastatin versus simvastatin for prevention of contrast-induced nephropathy.

Muñoz MA, Maxwell PR, Green K, Hughes DW, Talbert RL.

J Cardiovasc Pharmacol Ther. 2011 Sep-Dec;16(3-4):376-9. doi: 10.1177/1074248410394362. Epub 2011 Mar 8. Review.

PMID:
21386035
16.

Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study.

Hague WE, Simes J, Kirby A, Keech AC, White HD, Hunt D, Nestel PJ, Colquhoun DM, Pater H, Stewart RA, Sullivan DR, Thompson PL, West M, Glasziou PP, Tonkin AM; LIPID study investigators†.

Circulation. 2016 May 10;133(19):1851-60. doi: 10.1161/CIRCULATIONAHA.115.018580. Epub 2016 Mar 25. Review.

17.

Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.

Palmer SC, Craig JC, Navaneethan SD, Tonelli M, Pellegrini F, Strippoli GF.

Ann Intern Med. 2012 Aug 21;157(4):263-75. doi: 10.7326/0003-4819-157-4-201208210-00007. Review.

18.

Meta-analysis of statin effects in women versus men.

Kostis WJ, Cheng JQ, Dobrzynski JM, Cabrera J, Kostis JB.

J Am Coll Cardiol. 2012 Feb 7;59(6):572-82. doi: 10.1016/j.jacc.2011.09.067. Review. Erratum in: J Am Coll Cardiol. 2012 Apr 17;59(16):1491.

19.

Statins and Cardiovascular Primary Prevention in CKD: A Meta-Analysis.

Major RW, Cheung CK, Gray LJ, Brunskill NJ.

Clin J Am Soc Nephrol. 2015 May 7;10(5):732-9. doi: 10.2215/CJN.07460714. Epub 2015 Apr 1. Review.

20.

[Primary prevention of cardiovascular diseases with statins in women].

Alici G, Karpuz V, Karpuz H.

Turk Kardiyol Dern Ars. 2009 Jun;37(4):273-80. Review. Turkish.

Supplemental Content

Support Center